Stocks · News reference
RBC Capital Markets has increased its price target for Chemed Corporation to $585 from $548 while maintaining a Sector Perform rating.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Multiple financial institutions, including RBC, UBS, and Oppenheimer, have updated their price targets for Chemed Corporation following the company's third-quarter 2026 earnings report.
Bank of America has increased its price target for Chemed Corporation from $550 to $555 while maintaining a Buy rating.